Observe the Safety and Effectiveness of the WATCHMAN FLX™ for Subjects in Hong Kong
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Chan Chin Pang Gary
Prince of Wales Hospital, Shatin, Hong Kong
Principal Investigator - Fung Chi Yan Raymond
Princess Margaret Hospital, Canada
Principal Investigator - SF Chui
The Queen Elizabeth Hospital
Principal Investigator - Simon Lam
Queen Mary Hospital, Hong Kong
Principal Investigator - Tsui Kin Lam
Pamela Youde Nethersole Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Queen Mary Hospital
Hong Kong, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Jun 2020
- Primary completion
- 24 Jan 2022
- Completion
- 28 Mar 2023
- Last update posted
- 12 Aug 2024
- Registered enrollment
- 50
- Registry id
- NCT04096963
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.